Can a vitamin c and rutin combo tame fatty liver?
NCT ID NCT07310407
First seen Jan 06, 2026 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This phase 2 trial tests whether taking rutin and vitamin C together can reduce inflammation and oxidative stress in people with fatty liver disease (MASLD). 120 participants will take either the combination or vitamin C alone for 12 weeks, alongside diet and exercise advice. The study aims to see if these supplements can help control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAFLD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Hepatology and Tropical Medicine Research Institute (NHTMRI)
Cairo, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Rutin and Vitamin C
What this could lead to
If it works, this could point toward a simple, low-cost supplement combination to help manage fatty liver disease by reducing inflammation and oxidative stress.
What could go wrong
This is a small, early-phase trial (120 people) testing only short-term effects (12 weeks). The results may not lead to a proven treatment, and supplements are not a substitute for lifestyle changes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.